The ParagonCare Advantage
We’ve been delivering pharmaceuticals, capital equipment, diagnostics, medical consumables, devices and complementary medicines for over 100 years. We started out in Australia in 1918, and our transformational journey culminated in our 2024 merger of Clifford Hallam and Paragon Care. Today, we are an ASX-listed diversified healthcare leader, making healthcare simpler, smarter, and more accessible across Asia Pacific.
A Year of Growth
A year of solid performance and growth following a successful merger of systems, teams and processes in ParagonCare, CH2 and Oborne businesses across Asia Pacific.
$3.6 billion
Underlying Revenue
$95.2 million
Underlying EBITDA
$31.2 million
Underlying Net Profit After Tax
Latest Results
Previous ResultsPress Releases
All Press ReleasesCorporate Governance
Paragon Care Limited (ParagonCare) and the Board are committed to achieving and demonstrating the highest standards of corporate governance.
Learn MoreShareholder Communications
Recent legislative changes to the Corporations Act 2001 (Cth) mean there are new options available to Paragon Care Limited shareholders as to how you receive communications from Paragon Care Limited. Paragon Care Limited will no longer be sending physical meeting documents unless you request a copy to be posted.
Read MoreEnvironment, Social & Governance
Our commitment to care extends beyond what we create or deliver. It is reflected in how we treat people, uphold human rights, and respect the world around us. We believe responsible actions today help build a fairer and more sustainable tomorrow.
Read More